{"filings":[{"id":554958,"accession_number":"0001193125-26-232643","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-05-20T20:21:47+00:00","items":["5.02","9.01"],"status":"ready","headline":"Stryker CAO Berry to retire Sept 1, 2026; Baculik named successor as VP, CAO","event_type":"leadership","confidence":"high","bullets":["William Berry retires as VP, CAO effective Sept 1, 2026; will serve as Advisor to CFO until Aug 15, 2027.","Emily Baculik, currently VP Corporate Controller, becomes CAO on Sept 1, 2026.","Berry's base salary remains $510,000 during advisory period; eligible for 2026 bonus (50% target).","Baculik's base salary rises to $420,000 effective Sept 1, 2026; bonus target 45% of salary.","Recommendation for February 2027 LTI award to Baculik of $400,000 target value (50% options, 50% RSUs)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97895,"accession_number":"0000310764-26-000029","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Stryker shareholders elect directors, ratify auditor, approve exec compensation","event_type":"other_material","confidence":"high","bullets":["All ten director nominees elected; Emmanuel P. Maceda had highest dissent with 52.4M against (out of ~290M votes cast).","Ernst & Young LLP ratified as independent auditor for 2026: 284.7M for, 35.3M against, 0.4M abstain.","Advisory 'say-on-pay' resolution approved: 269.4M for, 18.6M against, 2.2M abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97894,"accession_number":"0000310764-26-000025","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance","event_type":"earnings","confidence":"high","bullets":["Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.","Reported EPS $1.93 (+14.2%); adjusted EPS $2.60 (-8.5%) as adjusted operating margin contracted 180bps to 21.1%.","Maintains FY2026 guidance: organic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10.","Company highlights recovery from cyber incident and new Ortho Tech organizational structure combining Mako and instruments."],"consensus_eps_estimate":null,"consensus_eps_actual":1.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":6020000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97893,"accession_number":"0001193125-26-149607","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K/A","filed_at":"2026-04-09T23:59:59+00:00","items":["1.05","7.01"],"status":"ready","headline":"Stryker says cyber incident materially impacted Q1 operations and financial results; full-year guidance unchanged","event_type":"cyber","confidence":"high","bullets":["Incident identified March 11, 2026; caused business disruptions.","Determined material impact on Q1 2026 operations and financial results.","No material impact expected on full-year 2026 guidance.","Global manufacturing, commercial, ordering, and distribution systems fully restored.","Q1 2026 earnings to be reported on April 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113083,"accession_number":"0001193125-26-118634","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Stryker updates cyber incident: contained, no customer data accessed per Unit 42","event_type":"cyber","confidence":"high","bullets":["Threat actor used malicious file to hide activity; file not capable of spreading internally or externally.","Investigation has not identified malicious activity directed at customers, suppliers, or partners.","Unit 42 letter confirms no persistent unauthorized access as of March 20, 2026; all IOCs addressed.","Impacted systems being rebuilt or restored; manufacturing ramping as lines come back online.","Company has not yet determined whether incident is reasonably likely to have a material impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113082,"accession_number":"0001193125-26-104431","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Stryker updates on cyber incident: operations disrupted, patient services unaffected","event_type":"cyber","confidence":"high","bullets":["Cybersecurity incident affecting Microsoft environment disclosed March 11; CISO provided update March 12.","Order processing, manufacturing, and shipping remain disrupted.","Patient-related services and connected products believed not impacted.","Investigation ongoing; full scope, nature, and financial impact not yet known.","Company does not believe patient data or connected devices were compromised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113081,"accession_number":"0001193125-26-102460","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Stryker reports global cybersecurity incident affecting Microsoft systems; investigation ongoing","event_type":"cyber","confidence":"high","bullets":["Incident detected March 11, 2026; global disruption to Microsoft environment; no ransomware or malware; contained.","Operations and corporate functions disrupted; restoration timeline unknown; business continuity measures activated.","Full scope, nature, and financial/operational impact not yet known; investigation continues with external advisors.","Company has not determined if incident will be material; forward-looking statements caution against uncertainty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113080,"accession_number":"0000310764-26-000006","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Stryker reports Q4 2025 sales $7.2B, +11% organic; 2026 outlook 8-9.5% organic growth","event_type":"earnings","confidence":"high","bullets":["Q4 reported EPS $2.20 (+56% YoY); adjusted EPS $4.47 (+11.5%).","Full year net sales $25.1B (+11.2% reported); organic growth 10.3%.","MedSurg & Neurotechnology Q4 organic sales +12.6%; Orthopaedics +8.4% organic.","Adjusted operating margin expanded 100 bps to 30.2% in Q4, 26.3% full year.","2026 guidance: organic sales growth 8.0%-9.5%; adjusted EPS $14.90-$15.10."],"consensus_eps_estimate":null,"consensus_eps_actual":8.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":25116000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129489,"accession_number":"0001193125-25-308097","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Stryker appoints Spencer Stiles as President and COO; Crotty promoted to Group President Orthopaedics","event_type":"leadership","confidence":"high","bullets":["Spencer Stiles appointed President & COO effective Jan 1, 2026; will lead global businesses, strategy, and M&A.","Dylan Crotty promoted to Group President, Orthopaedics, succeeding Stiles, effective same date.","Stiles' base salary increased to $1,000,000; LTIP target value ~$6,000,000 (40% options, 60% PSUs).","Crotty's base salary increased to $700,000; LTIP target value ~$3,000,000 (same equity mix).","Both are 27-year Stryker veterans; no family relationships or material transactions per filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129488,"accession_number":"0000310764-25-000126","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance","event_type":"earnings","confidence":"high","bullets":["Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).","Organic net sales +9.5% (volume +9.1%, price +0.4%); MedSurg/Neuro +8.4% organic.","Orthopaedics organic +11.4% (ex-divested Spinal +12.5%); adjusted op margin 25.6% (+90 bps).","FY 2025 guidance raised: organic sales growth 9.8%-10.2%, adj EPS $13.50-$13.60."],"consensus_eps_estimate":null,"consensus_eps_actual":6.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":17945000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146050,"accession_number":"0000310764-25-000103","cik":310764,"company_name":"STRYKER CORP","ticker":"SYK","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance","event_type":"earnings","confidence":"high","bullets":["Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).","Reported EPS $2.29 +7.0%; adjusted EPS $3.13 +11.4%. Adj. operating margin 25.7% +110 bps.","FY 2025 guidance raised: organic sales growth 9.5-10.0%, adj EPS $13.40-$13.60.","Tariff impact estimated at ~$175M net, reflecting US-China reduction and proposed US-EU framework."],"consensus_eps_estimate":null,"consensus_eps_actual":3.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":11888000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}